Patents by Inventor David M. Swope

David M. Swope has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for decreasing neurologic symptomatology
    Publication number: 20020119978
    Abstract: A method of decreasing signs or symptomatology of Parkinson's disease comprising selecting a patient having Parkinson's disease and administering to the patient an effective amount of sildenafil. A composition for decreasing the signs or symptomatology of Parkinson's disease comprising an effective amount of sildenafil and an effective amount of a different agent that decreases signs or symptomatology of Parkinson's disease when administered to patients having Parkinson's disease.
    Type: Application
    Filed: April 5, 2002
    Publication date: August 29, 2002
    Inventors: David M. Swope, Dale E. Neldner
  • Composition and method for decreasing neurologic symptomatology
    Patent number: 6380267
    Abstract: A method of decreasing the signs or symptomatology in a patient with a neurologic condition or disease, or in a patient due to effects of exposure to an exogenous substance, such as a pharmaceutical agent, comprising selecting a patient having at least one sign or symptom selected from the group consisting of akinesia, bradykinesia, dyskinesias, gait disturbances, posture disturbances, rigid limbs, speech impairments and tremor and administering to the patient one or more than one effective doses of a phosphodiesterase inhibitor.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: April 30, 2002
    Inventor: David M. Swope
  • Composition and method for decreasing neurologic symptomatology
    Publication number: 20020032203
    Abstract: A method of decreasing the signs or symptomatology in a patient with a neurologic condition or disease, or in a patient due to effects of exposure to an exogenous substance, such as a pharmaceutical agent, comprising selecting a patient having at least one sign or symptom selected from the group consisting of akinesia, bradykinesia, dyskinesias, gait disturbances, posture disturbances, rigid limbs, speech impairments and tremor and administering to the patient one or more than one effective doses of a phosphodiesterase inhibitor.
    Type: Application
    Filed: December 5, 2000
    Publication date: March 14, 2002
    Inventor: David M. Swope